Maruti Suzuki, HDFC Bank among top stocks buzzing in Thursday's session
Lupin has announced that it has launched Tobramycin Inhalation Solution USP, in the US market. Lupin had already received USFDA approval for Tobramycin Inhalation from the USFDA.
The Sensex and Nifty are expected to open lower on Thursday after Asian markets edged down as the Federal Reserve raised interest rates and took a more hawkish tone in forecasting a slightly faster pace of tightening for the rest of the year. At 8:00 am, SGX Nifty was trading at 10,814.50, down 30.50 points or 0.28 per cent.
MSCI's broadest index of Asia-Pacific shares outside Japan lost 0.25 per cent in early trade. South Korea's KOSPI was off 0.9 per cent, while Australia's market slipped 0.2 per cent.
Japan's Nikkei shed 0.7 per cent.
The Fed raised its benchmark overnight lending rate a quarter of a percentage point to a range of 1.75 per cent to 2 per cent, as expected, on the back of strong US economic growth.
Here are key stocks in news:
Lupin: Lupin has announced that it has launched Tobramycin Inhalation Solution USP, in the US market. Lupin had already received USFDA approval for Tobramycin Inhalation from the USFDA.
Adani Transmission: The firm has received a letter of intent of one Intra State Transmission Project in Uttar Pradesh. It has received the LOI from REC Transmission Projects Company Limited (A wholly owned subsidiary of Rural Electrification Corporation).
Maruti Suzuki: Sources say Maruti has halted the production of Maruti Ignis Diesel on account of low demand and rising diesel prices. The cost of Ignis is Rs 8 lakh. It had been launched in January 2017.
HDFC Bank: The government has approved the proposal for grant of permission to HDFC Bank to raise additional share capital of up to a maximum of Rs. 24,000 crore, including premium, over and above the previous approved limit of Rs. 10,000 crore, such that the composite foreign shareholding in the Bank shall not exceed 74% of the enhanced paid-up equity share capital of the bank.
WATCH ZEE BUSINESS VIDEO HERE
Canara Bank: The Board of Canara Bank in its meeting on Wednesday decided to raise Equity Share Capital amounting upto Rs 7000 Crore (including premium) by way of Qualified Institutional Placements(QIP) / Rights Issue / ESPS / Private Placement / Preferential allotment /any other approved means during Financial Year 2018-19 subject to market conditions and necessary approvals.